These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17 related articles for article (PubMed ID: 6273562)
1. The molecular basis for the mode of action of Beta-lactam antibiotics and mechanisms of resistance. Bycroft BW; Shute RE Pharm Res; 1985 Jan; 2(1):3-14. PubMed ID: 24272507 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives. Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors. Qadri SM; Ueno Y; Cunha BA Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide. Gottstein WJ; Crast LB; Graham RG; Haynes UJ; McGregor DN J Med Chem; 1981 Dec; 24(12):1531-4. PubMed ID: 6273562 [TBL] [Abstract][Full Text] [Related]
7. The role of beta-lactamase inhibitors in chemotherapy. Neu HC Pharmacol Ther; 1985; 30(1):1-18. PubMed ID: 3018803 [No Abstract] [Full Text] [Related]